Skip to main content

CITADEL ADVISORS LLC

Position in PHIO — Phio Pharmaceuticals Corp.

CIK 1423053 MIAMI, FL

Position in PHIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$48,328
-$31,818 QoQ
Shares Held
47,150
+5.9% QoQ
Ownership
0.406%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 24 holders
Holding Since
Sep 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PHIO Over Time

Shares Held

Position Value (USD)

Derivatives in PHIO

reported options exposure · as of Sep 30, 2022
CallValue
$6,623
CallShares
107
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. PHIO ranks #384 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PHIO

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $48,328 47,150
2024-12-31 $80,146 44,526
2024-06-30 $15,010 21,691
2023-12-31 $24,200 31,843
2022-09-30 $6,623 11,600
2021-12-31 $21,000 21,000
2021-12-31 $12,300 12,300
2021-12-31 $29,097 29,097
2021-09-30 $254,765 125,500
2021-09-30 $55,110 27,148
2021-09-30 $38,773 19,100
2021-06-30 $42,714 18,900
2021-06-30 $83,719 37,044
2021-06-30 $483,640 214,000
2021-03-31 $283,812 105,900
2021-03-31 $62,100 23,172
2020-09-30 $26,060 12,178